NCT06058728 2025-09-17
Pink Orchid
AbbVie
Withdrawn
Clinical Trials
9 trialsNCT01735812 2022-06-13
UFREEZE-01
IceCure Medical Ltd.
Phase NA Withdrawn
NCT04567095 2020-10-23
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada
Allergan
Withdrawn
NCT04567589 2020-10-22
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada
Allergan
Withdrawn
NCT03699176 2020-01-18
ASTEROID 7
Bayer
Phase 3 Withdrawn
NCT01328067 2018-06-15
Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids
InSightec
Phase NA Withdrawn
NCT00874302 2014-06-27
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Repros Therapeutics Inc.
Phase 3 Withdrawn
NCT00768742 2013-11-25
FAST
Gynesonics
Phase NA Withdrawn
NCT01553123 2013-02-07
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Watson Pharmaceuticals
Phase 3 Withdrawn